Trade Summary

5 days ago, Feider Stephen, serving as Chief Financial Officer at Beta Bionics, Inc. (BBNX), sold 10,000 shares at $17.04 per share, for a total transaction value of $170,387.20. Following this transaction, Feider Stephen now holds 165,931 shares of BBNX.

This sale represents a 5.68% decrease in Feider Stephen's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, June 26, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, June 30, 2026 at 4:46 PM ET, 4 days after the trade was made.

Beta Bionics, Inc. operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.